MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults.
about
A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiencyMore Favorable Metabolic Impact of Three-Times-Weekly versus Daily Growth Hormone Treatment in Naïve GH-Deficient ChildrenPharmacokinetic and Pharmacodynamic Modeling of MOD-4023, a Long-Acting Human Growth Hormone, in Growth Hormone Deficiency Children.The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency.Pharmacokinetics, Pharmacodynamics, and Safety of a Long-Acting Human Growth Hormone (MOD-4023) in Healthy Japanese and Caucasian Adults.
P2860
MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MOD-4023, a long-acting carbox ...... owth hormone-deficient adults.
@en
MOD-4023, a long-acting carbox ...... owth hormone-deficient adults.
@nl
type
label
MOD-4023, a long-acting carbox ...... owth hormone-deficient adults.
@en
MOD-4023, a long-acting carbox ...... owth hormone-deficient adults.
@nl
prefLabel
MOD-4023, a long-acting carbox ...... owth hormone-deficient adults.
@en
MOD-4023, a long-acting carbox ...... owth hormone-deficient adults.
@nl
P2093
P2860
P356
P1476
MOD-4023, a long-acting carbox ...... owth hormone-deficient adults.
@en
P2093
Beverly M K Biller
Christian J Strasburger
Janos Vadasz
Juraj Payer
L'udmila Trejbalová
Leanne Amitzi
László Bajnok
Marija Pfeifer
P2860
P304
P356
10.1530/EJE-16-0748
P577
2016-12-08T00:00:00Z